Promethera Biosciences to attend and present at Upcoming Scientific and Partnering Conferences in March and April

Mont-Saint-Guibert, Belgium, March 12, 2019 – Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced that the Company will give presentations and attend the following scientific and partnering conferences in Japan, Europe, and the US.

 

18th Congress of the Japanese Society for Regenerative Medicine 

Date: March 21-23, 2019

Venue: JSRM Convention Center, Kobe, Japan

Breakfast seminar on liver regeneration by allogenic mesenchymal stem cell therapy:

  • Session 1: Mesenchymal stem cells derived from adult human liver: an attractive expandable cell source to target hepatic deficiencies
    • Presenter: Mustapha Najimi, Special Advisor – Scientific Affairs
  • Session 2: HepaStem, adult liver mesenchymal stem cells for liver rescue therapy in ACLF and NASH
    • Presenter: Prof. Etienne Sokal, M.D., Ph.D., CMO/CSO
    • Date: March 23rd, 2019

 

BioEurope Spring

Date: March 25-27, 2019

Venue: Messe Wien Exhibition and Congress Center, Vienna, Austria

  • Panel:
    • Title: “What’s NEXT in NASH?”
    • Presenter: Pascale Jordan, Ph.D. Director BD, External Evaluation
    • Date: March 25th, 2019

 

The International Liver Congress™ 2019 (EASL)

Date: April 10-14, 2019

Venue: Messe Wien Exhibition and Congress Center, Vienna, Austria

  • Booth: Biotech Village booth #6

 

3rd Annual NASH Summit in Boston 

Date: April 22-25, 2019

Venue: Hilton Boston Logan Airport, Boston, MA, USA

  • Presentation:
    • Title: “HepaStem for the treatment of fibro-inflammatory liver diseases”
    • Date: April 22, 2019
    • Presenter: Nathalie Belmonte, Ph.D., VP Product Development

 

Cell & Gene Meeting on the Mediterranean

Date: April 23-25, 2019

Venue: Hotel Arts Barcelona, Barcelona, Spain

  • Panel:
    • Title: “Recent developments and predictions for the future of advanced therapies”
    • Presenter: John Tchelingerian, Ph.D., President & CEO
  • Company presentation:
    • Title: “HepaStem, adult liver medicinal signaling cells for liver rescue therapy in ACLF and NASH”
    • Presenter: Prof. Etienne Sokal, M.D., Ph.D., CMO/CSO
    • Date: April 24rd, 2019
Files
Sign Up